IRI — Integrated Research Cashflow Statement
0.000.00%
- AU$65.62m
- AU$26.77m
- AU$68.26m
- 71
- 98
- 17
- 69
Annual cashflow statement for Integrated Research, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 0.626 | 0 | — | — | — |
Other Operating Cash Flow | |||||
Cash from Operating Activities | 21.1 | 16.9 | 13.8 | 13 | 8.68 |
Capital Expenditures | -12.2 | -11.8 | -7.79 | -0.048 | -0.497 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 1.44 | 2.05 | 1.13 | 2.32 | 4.62 |
Sale of Business | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -10.8 | -9.75 | -6.66 | 2.27 | 4.12 |
Financing Cash Flow Items | -0.602 | -0.225 | -0.068 | -0.096 | -0.101 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -7.04 | -7.18 | -1.7 | -1.69 | -5 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2.4 | 0.18 | 6.22 | 13.3 | 8.67 |